Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

NIDA Home > Newsroom > News Release    

NIDA Deputy Director to Give Stimulant Abuse Update at ASAM Annual Scientific Meeting

For Release April 25, 2007

Team of Addiction Specialists to Discuss Latest Science on Stimulants

WHAT:

Treatment of Stimulant Dependence: The State of the Science

The National institute on Drug Abuse (NIDA), part of the National Institutes of Health, will present a full day symposium on the epidemiology of stimulant abuse and treatment as part of the 38th Annual Medical-Scientific Conference of the American Society of Addiction Medicine (ASAM). Led by NIDA Deputy Director Dr. Timothy P. Condon, NIDA experts will discuss the behavioral approaches that are currently the mainstay of treatment, the most recent studies involving contingency management techniques, and pharmacotherapeutic studies of marketed medications for the management of cocaine and methamphetamine dependence.

WHY:Abuse of stimulants continues to be a major public health problem in the United States. Neuroscience is uncovering new directions for medical therapies.
WHEN:Friday, April 27, 2007: Dr. Condon at Plenary (9:00 a.m.)
Saturday April 28, 2007
10:00 a.m. - 12 Noon
2:00 - 4:00 p.m.
WHERE:Marriott Doral Resort and Spa
Miami, Florida
WHO:Featured Speakers from NIDA:
Dr. Timothy P. Condon, Deputy Director, NIDA
Dr. Frank Vocci, Director, Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
Dr. Ahmed Elkashef, Chief of the Clinical Medical Branch, DPMCDA
Dr. Wilson Compton, Director, Division of Epidemiology, Services and Prevention Research (DESPR)

Other Featured Speakers:
Dr. Kyle Kampman and Dr. Charles Dackis, University of Pennsylvania
Dr. Kathleen Brady, Medical University of South Carolina
Dr. Nancy Petry, University of Connecticut School of Medicine
Dr. Walter Ling, UCLA School of Medicine
A full agenda and speaker list of the ASAM meeting can be found at www.asam.org.

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and further information on NIDA research can be found on the NIDA web site at http://www.drugabuse.gov.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary Federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov


NIDA News Release Logo

For more information about any item in this Release Contact:

Get Adobe Reader

Download PDF [112 KB]


Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal